Duration of depressive symptoms and mortality risk: the English Longitudinal Study of Ageing (ELSA).
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 26795425.
- Also identified by DOI 10.1192/bjp.bp.114.155333 and PMC identifier 4816969.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The relationship between the duration of depressive symptoms and mortality remains poorly understood. To examine whether the duration of depressive symptoms is associated with mortality risk. Data (n= 9560) came from the English Longitudinal Study of Ageing (ELSA). We assessed depressive symptom duration as the sum of examinations with an eight-item Center for Epidemiologic Studies Depression Scale score of ⩾3; we ascertained mortality from linking our data to a national register. Relative to those participants who never reported symptoms, the age- and gender-adjusted hazard ratios for elevated depressive symptoms over 1, 2, 3 and 4 examinations were 1.41 (95% CI 1.15-1.74), 1.80 (95% CI 1.44-2.26), 1.97 (95% CI 1.57-2.47) and 2.48 (95% CI 1.90-3.23), respectively (Pfor trend <0.001). This graded association can be explained largely by differences in physical activity, cognitive function, functional impairments and physical illness. In this cohort of older adults, the duration of depressive symptoms was associated with mortality in a dose-response manner.
Medical subject headings
- Aging
- Depression